Erika Rijavec

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Maria Giovanna Dal Bello, Rosangela Filiberti, Angela Alama et al. · Journal of Translational Medicine · 2019 · 203 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer

Sandra Salvi, Vincenzo Fontana, Simona Boccardo et al. · Cancer Immunology Immunotherapy · 2012 · 134 citations · Full text

Medicine, Immunology, Oncology +15

Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients

Matteo Sarocchi, Francesco Grossi, Eleonora Arboscello et al. · The Oncologist · 2018 · 89 citations

Medicine, Cardiology, Oncology +16

Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non–Small Cell Lung Cancer: ¹⁸F-FDG PET/CT Study

Silvia Morbelli, Angela Alama, Giulia Ferrarazzo et al. · Journal of Nuclear Medicine · 2017 · 50 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

Anna Truini, Simona Coco, Ernest Nadal et al. · Oncotarget · 2017 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +17